CHICAGO — A Fas inhibitor showed strong efficacy signals and demonstrated in patients with more than 8 days of macula-off rhegmatogenous retinal detachment, according to a study. A Fas inhibitor ...
ANN ARBOR, Mich., April 12, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal ...
When vision deteriorates, it's easy to dismiss it as just 'getting older.' However, it could be a sign of retinal disease, ...
The retina is a layer of tissue at the back of the eye that converts visual images into nerve impulses in the brain. Injuries to the eye can cause layers of the retina to separate, which is known as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback